Correlation Between Lexicon Pharmaceuticals and Verrica Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lexicon Pharmaceuticals and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexicon Pharmaceuticals and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lexicon Pharmaceuticals and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Lexicon Pharmaceuticals and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexicon Pharmaceuticals with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexicon Pharmaceuticals and Verrica Pharmaceuticals.

Diversification Opportunities for Lexicon Pharmaceuticals and Verrica Pharmaceuticals

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Lexicon and Verrica is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Lexicon Pharmaceuticals and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Lexicon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexicon Pharmaceuticals are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Lexicon Pharmaceuticals i.e., Lexicon Pharmaceuticals and Verrica Pharmaceuticals go up and down completely randomly.

Pair Corralation between Lexicon Pharmaceuticals and Verrica Pharmaceuticals

Given the investment horizon of 90 days Lexicon Pharmaceuticals is expected to generate 1.69 times more return on investment than Verrica Pharmaceuticals. However, Lexicon Pharmaceuticals is 1.69 times more volatile than Verrica Pharmaceuticals. It trades about -0.05 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest  72.00  in Lexicon Pharmaceuticals on December 29, 2024 and sell it today you would lose (37.00) from holding Lexicon Pharmaceuticals or give up 51.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Lexicon Pharmaceuticals  vs.  Verrica Pharmaceuticals

 Performance 
       Timeline  
Lexicon Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Lexicon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Verrica Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Verrica Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Lexicon Pharmaceuticals and Verrica Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lexicon Pharmaceuticals and Verrica Pharmaceuticals

The main advantage of trading using opposite Lexicon Pharmaceuticals and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexicon Pharmaceuticals position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.
The idea behind Lexicon Pharmaceuticals and Verrica Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope